|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30,400 KRW | +2.01% |
|
+4.29% | -14.49% |
| Mar. 14 | JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 22 | CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions | MT |
JW Pharmaceutical Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 3,438.17 million compared to KRW 3,802.59 million a year ago. Net income was KRW 37,006.33 million compared to KRW 31,891.68 million a year ago.
Basic earnings per share from continuing operations was KRW 1,504 compared to KRW 1,305 a year ago. Basic earnings per share was KRW 1,504 compared to KRW 1,305 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.49% | 515M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
JW PHARMACEUTICAL CORPORATION 
